Catherine Bartlett

Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with <i>in vivo</i> antiresorptive activity

William C. Shakespeare, Michael G. Yang, Regine S. Bohacek et al. · Proceedings of the National Academy of Sciences · 2000 · 133 citations · Full text

Medicinal Chemistry, Sclerostin, Biochemistry +15

Transgenic Expression of a Variant of Human Tissue-Type Plasminogen Activator in Goat Milk: Purification and Characterization of the Recombinant Enzyme

Julie Denman, M. Anthony Hayes, Christine O’Day et al. · Nature Biotechnology · 1991 · 101 citations

Caprine, Developmental Biology, Engineering +8

Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70

Chi B. Vu, Evelyn G. Corpuz, Taylor Merry et al. · Journal of Medicinal Chemistry · 1999 · 88 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +15

1H NMR studies on an Asn-linked glycopeptide. GlcNAc-1 C2-N2 bond is rigid in H2O.

Jeffery T. Davis, S Hirani, Catherine Bartlett et al. · Journal of Biological Chemistry · 1994 · 59 citations · Full text

A Src SH2 selective binding compound inhibits osteoclast-mediated resorption

Shelia M. Violette, William C. Shakespeare, Catherine Bartlett et al. · Chemistry & Biology · 2000 · 59 citations · Full text

Osteoclast-mediated Resorption, Signal Transduction, Biochemistry +4